Literature DB >> 12090551

Estrogen and Alzheimer's disease.

Andrea LeBlanc1.   

Abstract

The potential of estrogen as a therapeutic intervention in the prevention or treatment of neurodegenerative diseases has been the object of much research in the past five years. While clinical research has produced highly diverse results in different studies, basic research has uncovered a number ofmolecular mechanisms which dearly label estrogen as a neuroprotective agent. This short review summarizes the various research results that indicate how estrogen can be beneficial to neurons in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12090551

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  3 in total

1.  ERGDB: Estrogen Responsive Genes Database.

Authors:  Suisheng Tang; Hao Han; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

2.  Progress in the development of new drugs in Alzheimer's disease.

Authors:  Antoine Piau; F Nourhashémi; C Hein; C Caillaud; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

3.  Donepezil treatment restores the ability of estradiol to enhance cognitive performance in aged rats: evidence for the cholinergic basis of the critical period hypothesis.

Authors:  R B Gibbs; R Mauk; D Nelson; D A Johnson
Journal:  Horm Behav       Date:  2009-03-20       Impact factor: 3.587

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.